What is Arvinas Inc (ARVN)?
Arvinas Inc is a biopharmaceutical company focused on the development of targeted protein degradation therapies. The company utilizes a proprietary technology platform to design small molecules that selectively degrade disease-causing proteins. Arvinas aims to address diseases with high unmet medical needs, including certain cancers and neurodegenerative disorders. Its research and development efforts concentrate on advancing novel therapeutic candidates through clinical trials. The company collaborates with academic institutions and industry partners to enhance its drug discovery capabilities. Arvinas represents a segment of the biotechnology industry dedicated to innovative approaches in drug development.
Arvinas Inc Stock Price Today: Live Overview
The price today is shaped by Arvinas Inc's current trading level of $10.98. The price has moved between $10.65 and $11.09 today, showing a daily percentage change of 0%.
FAQ: Arvinas Inc (ARVN)
What is the current price of ARVN stock?
The current trading price is $10.98.
Does ARVN pay dividends?
Arvinas Inc does not pay dividends.
Does ARVN have a formal corporate presence or regional headquarters in the UAE?
Arvinas Inc has no official presence or subsidiary in the UAE and operates through distributors and partners only.
What is ARVN best known for?
The company is most famous for its development of targeted protein degradation therapies.
What assets are typically shown together with ARVN?
Commonly shown alongside ARVN: BioXcel Therapeutics, Inc., Above Food Ingredients Inc, Cardiff Oncology, Inc.
Latest shares articles



